Companies/US/ENLV

ENLIVEX LTD.

Last · NasdaqCM$0.253-0.001 (-0.39%)stale · yahoo · 59h ago
Vol 870.2K ≈ 220.2K
Market cap$5.04M19.9M sh
P/E · TTM0.0fwd -0.3 · eps 494.00
Beta1.41vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.224$27.15
Volume870.2Ksession

Issuer

Legal nameENLIVEX LTD.
HQUnited States (US)
ListingUS ENLV
ISINIL0011319527
LEI549300BG1T7KL678Y212
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001596812
CIK0001596812
Websitewww.enlivex.com
LinkedIn
Employees34
AddressEnlivex Therapeutics Ltd. 14 Einstein Street 7403618, Ness Ziona
Loading chart…

Press & signals

1 recent
  • GlobeNewswire

    Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis

Documents

FormReporting forFiledFlags
6-K
—2026-08-110
6-K
—2026-07-300
6-K
—2026-07-290
6-K
—2026-07-280
6-K
—2026-07-280
Showing 5 of 67 filings